The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery

被引:11
作者
Chandeying, Nutthaporn [1 ]
Hanprasertpong, Jitti [1 ]
机构
[1] Prince Songkla Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Fac Med, Hat Yai 90110, Thailand
关键词
Histology; cervical cancer; radical hysterectomy; prognostic; survival; SQUAMOUS-CELL CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; PELVIC RADIATION-THERAPY; ADENOSQUAMOUS CARCINOMA; UTERINE CERVIX; IB ADENOCARCINOMA; HYSTERECTOMY; SURVIVAL; RADIOTHERAPY; DIFFERENCE;
D O I
10.1080/01443615.2016.1245279
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of this study was to determine the prognostic impact of histological type among squamous cell carcinoma (SCC), adenocarcinoma (AC) and adenosquamous carcinoma (ASC) on the treatment outcome of early-stage cervical cancer patients after radical hysterectomy. The cohort comprised of 626 patients, diagnosed with stages IA2-IB1 cervical cancer between 1987 and 2013. Four hundred and one patients had SCC, 190 had AC and 35 had ASC. The 5-year disease-free survival (DFS) rates for AC, SCC and ASC were 89.3% (95%CI 83.2-93.2), 88.7% (95%CI 84.8-91.7) and 82.1% (95%CI 61.9-92.2), respectively (p=.594). In multivariate analyses, only older age and deep stromal invasion were statistically significantly associated with DFS, whereas histologic cell type was not (p=.524). Subgroup analysis showed that in the intermediate-high-risk groups, the SCC group had a significantly longer DFS, compared with the AC group or the ASC group (p=.001) while there was no DFS difference in the low-risk group. We believe that histologic cell type had no impact in low-risk early-stage cervical cancer patients. However, in the intermediate-high-risk groups, SCC is a more favourable factor for survival than AC/ASC.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 29 条
[1]   COMPARISON OF ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A POPULATION-BASED EPIDEMIOLOGIC-STUDY [J].
ANTONCULVER, H ;
BLOSS, JD ;
BRINGMAN, D ;
LEEFELDSTEIN, A ;
DISAIA, P ;
MANETTA, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (05) :1507-1514
[2]   A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma [J].
Ayhan, A ;
Al, RA ;
Baykal, C ;
Demirtas, E ;
Yüce, K ;
Ayhan, A .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (02) :279-285
[3]   Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery [J].
Baek, Min-Hyun ;
Park, Jeong-Yeol ;
Kim, Daeyeon ;
Suh, Dae-Shik ;
Kim, Jong-Hyeok ;
Kim, Yong-Man ;
Kim, Young-Tak ;
Nam, Joo-Hyun .
GYNECOLOGIC ONCOLOGY, 2014, 135 (03) :462-467
[4]   Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan [J].
Chen, RJ ;
Lin, YH ;
Chen, CA ;
Huang, SC ;
Chow, SN ;
Hsieh, CY .
GYNECOLOGIC ONCOLOGY, 1999, 73 (02) :184-190
[5]  
Chittithaworn S, 2007, ASIAN PAC J CANCER P, V8, P530
[6]   Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: An outcomes analysis [J].
dos Reis, Ricardo ;
Frumovitz, Michael ;
Milam, Michael R. ;
Capp, Edison ;
Sun, Charlotte C. ;
Coleman, Robert L. ;
Ramirez, Pedro T. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (03) :458-463
[7]   ADENOCARCINOMA AS AN INDEPENDENT RISK FACTOR FOR DISEASE RECURRENCE IN PATIENTS WITH STAGE IB CERVICAL-CARCINOMA [J].
EIFEL, PJ ;
BURKE, TW ;
MORRIS, M ;
SMITH, TL .
GYNECOLOGIC ONCOLOGY, 1995, 59 (01) :38-44
[8]   Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma [J].
Farley, JH ;
Hickey, KW ;
Carlson, JW ;
Rose, GS ;
Kost, ER ;
Harrison, TA .
CANCER, 2003, 97 (09) :2196-2202
[9]   Prognostic significance of adenocarcinoma histology in women with cervical cancer [J].
Galic, Vijaya ;
Herzog, Thomas J. ;
Lewin, Sharyn N. ;
Neugut, Alfred I. ;
Burke, William M. ;
Lu, Yu-Shiang ;
Hershman, Dawn L. ;
Wright, Jason D. .
GYNECOLOGIC ONCOLOGY, 2012, 125 (02) :287-291
[10]  
Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO